Implantable Cardioverter Defibrillators: Technology, Indications, Implantation Techniques, and Follow-Up

Electrophysiological Disorders of the Heart

Volumn , Issue , 2005, Pages 809-834

  Madan, Nandini ^a,b   Saksena, Sanjeev ^c,d   Preminger, Mark ^c,e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d PBI Regional Medical Center   (United States)

^e ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745514248     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06570-5.50046-0     Document Type: Chapter

References (86)

1. LA Cobb, RS Baum, H Alvarez 3rd, et al. (1975) Resuscitation from outof-hospital ventricular fibrillation: 4 years follow-up. Circulation 52 223.
2. MH Lehmann, RT Steinman, CD Schuger, et al. (1998) The automatic implantable cardioverter defibrillator as the treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 62 803.
3. RH Myerberg and A Castellanos (1992) Evolution, evaluation and efficacy of the implantable cardioverter defibrillator technology. Circulation 86 691.
4. G Gregoratos, C Cheitlin, A Conill, et al. (1998) ACC/AHA guidelines for the implantation of cardiac pacemakers and antiarrhythmia devices. A report on the American College of Cardiology/American Heart Association (Committee on Pacemaker Implantation). J Am Coll Cardiol 31 1175.
5. S Saksena and V Parsonnet (1988) Implantation of an implantable cardioverter/defibrillator without thoracotomy using a triple electrode system. J Am Med Assoc 259 69-72.
6. S Saksena and H An (1990) Clinical efficacy of dual electrode systems for endocardial cardioversion of ventricular tachycardia: A prospective randomized crossover trial. Am Heart J 119 15-22.
7. AN Munsif, S Saksena, P DeGroot, et al. (1997) Low-energy endocardial defibrillation using dual, triple, and quadruple electrode systems. Am J Cardiol 79 1632-1639.
8. S Saksena, H An, R Mehra, P DeGroot, et al. (1992) Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 70 304-310.
9. S Saksena, P Chandran, Y Shah, et al. (1985) Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: A prospective, randomized, crossover study. Circulation 72 153-160.
10. JJ Neglia, RB Krol, I Giogorberedze, et al. (1997) Evaluation of a programming algorithm for the third tachycardia zone in a fourth generation implantable cardioverter. Defibrillator 1 49-54.
11. MH Raitt, EG Renfroe, AE Epstein, et al. (2001) The AVID Investigators. Ventricular tachycardia is not a benign rhythm: Insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Circulation 103 244-252.
12. S Saksena (1994) For the PCD Investigator Group: Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study. J Am Coll Cardiol 23 1521-1530.
13. BD Lindsay, S Saksena, ST Rothbart, et al. (1987) Prospective evaluation of a sequential pacing and high energy bidirectional shock algorithm for transvenous cardioversion in patients with ventricular tachycardia. Circulation 76 601-609.
14. BG Hook, DJ Callans, RB Kleinmann, et al. (1993) Implantable cardioverter defibrillator; implantable cardioverter defibrillator therapy in the absence of significant symptoms: Rhythm diagnosis and management aided by stored electrograms analysis. Circulation 87 1897-1906.
15. C Timmermans and R Tavenier (1998) and the Worldwide Metrix Investigators: Ambulatory use of the Metrix automatic implantable atrial defibrillator to treat episodes of atrial fibrillation. PACE 21 811.
16. C Swerdlow, W Schls, B Dijkmann, et al. (2000) The Worldwide Jewel AF investigators: Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. Circulation 101 878.
17. SW Adler, C Wolpert, E Warmann, et al. (2001) The Worldwide Jewel AF Investigators: Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 104 1023-1028.
18. R Cooper, W Smith and RE Ideker (1997) Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways. Circulation 96 2693-2700.
19. Bardy G, Lee K, Mark D, et al: The Sudden Cardiac Death in Heart Failure Trial. Presented at the Late Breaking Clinical Trials Session, American College of Cardiology Annual Scientific Session, March 8, 2004, New Orleans, LA.
20. MR Bristow, LA Saxon, J Boehmer, et al. (2004) Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med 350 2140-2150.
21. A Garson Jr, M Dick 2nd, A Fournier, et al. (1993) The long QT syndrome in children: An international study of 287 patients. Circulation 87 1866.
22. RG Weintraub, RM Gow and JL Wilkinson (1990) The congenital long QT syndrome in childhood. J Am Coll Cardiol 16 674.
23. J Kron, MJ Silka, OJ Ohm, et al. (1994) Preliminary experience with nonthoracotomy ICDs in young patients. The Medtronic Transvene investigators. PACE 17 26.
24. DW Benson, DG Benditt, R Anderson, et al. (1983) Cardiac arrest in young, ostensibly healthy patients: Clinical, hemodynamic, and electrophysiologic findings. Am J Cardiol 52 65.
25. EFD Wever, RNW Hauer, A Oomen, et al. (1993) Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 88 1021.
26. S Viskin and B Belhassen (1990) Idiopathic ventricular fibrillation. Am Heart J 120 662.
27. HJJ Wellens, R Lemery, JL Smeets, et al. (1992) Sudden arrhythmic death without overt heart disease. Circulation 85(suppl), 92.
28. B Maron, J Gardin, J Flack, et al. (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92 785.
29. B Maron, WC Roberts and SE Epstein (1982) Sudden unexpected death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 67 1388.
30. B Maron, WK Shen, M Link, et al. (2000) Efficacy of implantablecardioverter defibrillator for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 365.
31. L Fananapazir and SE Epstein (1991) Hemodynamic and electrophysio-logic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 13 1283.
32. WJ McKenna, RCG Franklin, P Nihoyannopoulos, et al. (1988) Arrhythmias and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 11 147.
33. H Watkins, A Rosenzweig, DS Hwang, et al. (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326 1108.
34. G Steinbeck, U Dorwarth, S Mattke, et al. (1994) Hemodynamic deterioration during ICD implant: Predictors of high-risk patients. Am Heart J 127(suppl), 1064.
35. V Fuster, BJ Gersh, ER Guiliani, et al. (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47 525.
36. WP Follansbee, EL Michelson and J Morganroth (1980) Nonsustained ventricular tachycardia in ambulatory patients: Characteristics and association with sudden cardiac death. Ann Intern Med 92 741.
37. PG Milner, JP DiMarco and BB Lerman (1988) Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. PACE 11 562.
38. B Dietmar, M Antz, B Boczor, et al. (2001) Prophylactic use of cardioverter-defibrillator in patients with implantable-cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). J Am Coll Cardiol 38 598.
39. A Kadish, A Dyer, JP Daubert, et al. (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 2151-2158.
40. JP DiMarco, H Garan, JW Harthorne, et al. (1981) Intracardiac electro-physiologic techniques in recurrent syncope of unknown cause. Ann Intern Med 95 542.
41. M Akhtar, M Shenasa, J Denker, et al. (1983) Role of cardiac electro-physiologic studies in patients with unexplained recurrent syncope. PACE 6 192.
42. L Watkins, M Mirowski, MM Mower, et al. (1982) Implantation of the automatic defibrillator: The subxiphoid approach. Ann Thorac Surg 34 515.
43. S Saksena, A Prakash, Mongeon, et al. (1995) Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 76 913-921.
44. R Boccadamo (1991) Antitachycardia pacemakers for supraventricular tachycardias. B Luderitz, S Saksena (Eds) Interventional Electrophysiology Mount Kisco, NY: Futura 213-224.
45. I Giorgberidze, S Saksena, L Mongeon, et al. (1997) Effects of high-frequency atrial pacing in atypical atrial flutter and atrial fibrillation. J Intervent Card Electrophysiol 1 111-123.
46. L Dreifus (1991) Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Report of the American College of Cardiology/American Heart Association Task Force on the assessment of cardiovascular procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol 18 1-13.
47. DP Zipes and D Roberts (1995) The PCD investigators: Results of the international study of the implantable pacemaker-cardioverterdefibrillator: A comparison of epicardial and endocardial lead systems. Circulation 92 59.
48. M Elder, MJ Sauve and MM Scheinmann (1987) Electrophysiologic testing and follow-up in patients with aborted sudden-death. J Am Coll Cardiol 10 291.
49. CD Swerdlow, RA Winkle and JW Mason (1983) Determinants of survival of patients with ventricular tachyarrhythmias. N Engl J Med 308 1436.
50. The CASCADE Investigators (1991) Cardiac arrest in Seattle: Conventional versus amiodarone drug evaluation. Am J Cardiol 67 578.
51. S Saksena, GB Breithardt, P Dorian, et al. (1996) Nonpharmacologic therapy for malignant ventricular arrhythmias: Implantable defibrillator trials. Prog Cardiovasc Dis 38 429.
52. S Nisam, SA Kay, MM Mower, et al. (1995) AICD automatic cardioverterdefibrillator clinical update: 14 years experience in over 34,000 patients. PACE 18 142.
53. The Antiarrhythmics Versus Implantable Defibrillators (AVID) investigators: (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 1576.
54. SJ Connolly, M Gent, R Roberts, et al. (2000) The CIDS Investigators Canadian Implantable Defibrillator Study (CIDS): A randomized trial of implantable defibrillator against amiodarone. Circulation 101 1297.
55. B Siebels Luderitz and S Saksena (1994) Proceeding of a symposium. Electrical device therapy for cardiac arrhythmias: New concepts, problems, and alternatives. Suppl Am Heart J 127 969.
56. J Kron, J Herre, EG Renfroe, et al. (2001) The AVID Investigators: Lead and device-related complications in the antiarrhythmic versus implantable defibrillators Trial. Am Heart J 141 92.
57. AJ Moss, WJ Hall, DS Cannom, et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial investigators. N Engl J Med 335 15.
58. DJ Wilber, H Garan and JN Ruskin (1987) Electrophysiologic testing in survivors of cardiac arrest. Circulation 75(4 P2), IIII146-IIII153.
59. AI Mushlin, JW Hall, J Zwanger, et al. (1998) The cost-effectiveness of automatic implantable cardioverter defibrillators: Results from MADIT. Circulation 97 2129-2135.
60. PJ Tchou, N Kadri, J Anderson, et al. (1988) Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 109 529.
61. K Axtell, P Tchou and M Akhtar (1991) Survival in patients with depressed left ventricular function treated by implantable cardioverterdefibrillator. PACE 14 291.
62. D Mehta, S Saksena and RB Krol (1992) Survival of implantable cardioverter-defibrillator recipients: Role of left ventricular function and its relationship to device use. Am Heart J 124 1608.
63. MJ Domanski, S Saksena, AE Epstein, et al. (1999) The AVID Investigators: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 34 1090-1095.
64. AJ Moss, W Zareba, WJ Hall, et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 833-877.
65. H Trappe, P Pfitzner, J Heintze, et al. (1995) Cardioverter-defibrillator implantation in the catheterization laboratory: Initial experience in 46 patients. Am Heart J 129 259.
66. SA Strickberger, M Niebauer, K Ching Man, et al. (1995) Comparison of implantation of nonthoracotomy defibrillators in the operating room versus electrophysiologic laboratory. Am Heart J 75 25.
67. JE Magney, DM Flynn, JA Parsons, et al. (1993) Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads, and failure of central venous catheters adjacent to the sternoclavicular joint. PACE 16 445.
68. LS Ong, SS Barold, M Lederman, et al. (1987) Cephalic vein guidewire technique for implantation of permanent pacemakers. Am Heart J 114(4 Part 1), 753.
69. JE Magney, DH Staplin, DM Flynn, et al. (1993) A new approach to percutaneous subclavian venipuncture to avoid lead fracture or central venous catheter occlusion. PACE 16 2133.
70. ST Higano, DL Hayes and PC Spittell (1990) Facilitation of the subclavianintroducer technique with contrast venography. PACE 13 681.
71. AE Epstein, WM Miles, DM Benditt, et al. (1996) Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations. Circulation 94 1147-1156.
72. SC Vlay, LC Olson, GL Fricchione, et al. (1989) Anxiety and anger in patients with ventricular tachyarrhythmias: Responses after automatic internal cardioverter-defibrillator implantation. PACE 12 366.
73. B Luderitz, W Jung, A Deister, et al. (1993) Patient acceptance of the implantable-cardioverter defibrillator in ventricular tachyarrhythmias. PACE 16 1815.
74. WL Winters, JL Achord, AW Boone, et al. (2000) American College of Cardiology/American Heart Association Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation and Cardioversion. J Am Coll Cardiol 36 1725.
75. MM Faust, J Fraser, LS Schurig, et al. (1990) Educational guidelines for the clinically associated professional in cardiac pacing and electrophysiology. PACE 17 6.
76. JG Fetter, MS Stanton, DG Benditt, et al. (1995) Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator. PACE 18 1531.
77. FE Marchlinski, DJ Callans, CD Gottlieb, et al. (1995) Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 6 832-835.
78. DJ Callans, BJ Hook and FE Marchlinski (1991) Use of bipolar recordings from patch-patch and rate sensing leads to distinguish rhythms in patients with implantable cardioverter defibrillators. PACE; 14 1917-1922.
79. W Grimm, BF Flores and FE Marchilinski (1993) Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable-cardioverter defibrillator. Am J Cardiol 71 1415-1418.
80. W Grimm, BF Flores and FE Marchilinski (1992) Electrocardiographically demonstrated unnecessary spontaneous shocks in 241 patients with implantable cardioverter defibrillators. PACE 15 1667-1673.
81. P Mathew, C Lewis, J Neglia, et al. (1997) Interactions between electronic surveillance systems and implantable defibrillators: Insights from a fourth generation ICD. Pacing Clin Electrophysiol 29 2857-2859.
82. ME McIvor, J Reddington, E Floden, et al. (1998) Study of Pacemaker and Implantable Cardioverter Defibrillator Triggering by Electronic Article Surveillance Devices (SPICED TEAS). Pacing Clin Electrophysiol 21 1847-1861.
83. CD Gottlieb and LN Horowitz (1991) Potential interactions between antiar-rhythmic medications and the automatic implantable cardioverter defibrillator. PACE 898-904.
84. RJ Haberman, EP Veltri and MM Mower (1988) The effect of amiodarone on defibrillation threshold. J Electrophysiol 5 415-419.
85. W Jung, M Manz, L Pizulli, et al. (1992) Effects of long-term amiodarone on defibrillation threshold. Am J Cardiol 70 1023.
86. J Kron, J Herre, EG Renfroe, et al. (2001) Lead- and device-related complications in the antiarrhythmias versus implantable defibrillator trial. Am Heart J 141 92-98.